Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chitosan + hyaluronate is an experimental hybrid hydrogel formulation developed by Ain Shams University for the treatment of temporomandibular joint (TMJ) internal derangement. The combination integrates the lubricating and anti-inflammatory properties of hyaluronic acid with the mucoadhesive and structural stability provided by chitosan. It is administered via intra-articular injection into the upper joint compartment following arthroscopic lysis and lavage. The gel is specifically investigated for patients with Wilkes Stage III or IV anterior disc displacement without reduction, aiming to improve joint mobility, reduce pain, and eliminate clicking sounds.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chitosan + hyaluronate.